Cyllene Therapeutics
Develops DNA medicines for severe neurogenic bladder conditions and other neurological diseases
€33MSeries C
Role not disclosedActivity from announced rounds
Develops DNA medicines for severe neurogenic bladder conditions and other neurological diseases
Develops prescription therapeutics and skincare products for cellular longevity and skin health